SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.
How Trump’s approach to regulating AI in health care could diverge from Biden’s
A lot has happened with artificial intelligence since President-elect Donald Trump was last in the White House. Nudged into action by the advent of generative